Cite
HARVARD Citation
Dieckmann, K. et al. (2022). Single-course bleomycin, etoposide, and cisplatin (1xBEP) as adjuvant treatment in testicular nonseminoma clinical stage 1: outcome, safety, and risk factors for relapse in a population-based study. Therapeutic advances in medical oncology. p. . [Online].